Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1 - PubMed (original) (raw)
Lymphoid cells transformed by Abelson virus require the v-abl protein-tyrosine kinase only during early G1
Y Y Chen et al. Proc Natl Acad Sci U S A. 1992.
Abstract
Cells infected with temperature-sensitive transformation mutants of the Abelson murine leukemia virus express low levels of kinase activity at the nonpermissive temperature, causing transformed pre-B cells to die under these conditions. Examination of cell cycle profiles of such populations prior to cell death reveals that the cells accumulate in the G1 phase of the cell cycle. Following G1 arrest, the cells die via apoptosis, an active process of cell elimination. Cell synchronization and temperature-shift experiments show that G1 arrest reflects the requirement for a functional v-abl protein during early G1 and that the molecule is not required at other phases of the cell cycle. These data indicate that the substrate(s) critical to v-abl-mediated transformation is involved in regulating G1 transit and that these interactions are dominant over all other changes required for the multistep process that results in the fully malignant phenotype associated with v-abl expression in lymphoid cells.
Similar articles
- An active v-abl protein tyrosine kinase blocks immunoglobulin light-chain gene rearrangement.
Chen YY, Wang LC, Huang MS, Rosenberg N. Chen YY, et al. Genes Dev. 1994 Mar 15;8(6):688-97. doi: 10.1101/gad.8.6.688. Genes Dev. 1994. PMID: 7926759 - Ras complements the carboxyl terminus of v-Abl protein in lymphoid transformation.
Parmar K, Rosenberg N. Parmar K, et al. J Virol. 1996 Feb;70(2):1009-15. doi: 10.1128/JVI.70.2.1009-1015.1996. J Virol. 1996. PMID: 8551558 Free PMC article. - Active Akt and functional p53 modulate apoptosis in Abelson virus-transformed pre-B cells.
Gong L, Unnikrishnan I, Raghavan A, Parmar K, Rosenberg N. Gong L, et al. J Virol. 2004 Feb;78(4):1636-44. doi: 10.1128/jvi.78.4.1636-1644.2004. J Virol. 2004. PMID: 14747529 Free PMC article. - Inhibition of Abelson oncogene function by erbstatin analogues.
Kawada M, Tawara J, Tsuji T, Honma Y, Hozumi M, Wang JY, Umezawa K. Kawada M, et al. Drugs Exp Clin Res. 1993;19(6):235-41. Drugs Exp Clin Res. 1993. PMID: 8013266 Review. - Abl-mediated transformation, immunoglobulin gene rearrangements and arrest of B lymphocyte differentiation.
Rosenberg N. Rosenberg N. Semin Cancer Biol. 1994 Apr;5(2):95-102. Semin Cancer Biol. 1994. PMID: 8061334 Review.
Cited by
- Absence of p53 complements defects in Abelson murine leukemia virus signaling.
Unnikrishnan I, Rosenberg N. Unnikrishnan I, et al. J Virol. 2003 Jun;77(11):6208-15. doi: 10.1128/jvi.77.11.6208-6215.2003. J Virol. 2003. PMID: 12743277 Free PMC article. - NF-kappaB1 can inhibit v-Abl-induced lymphoid transformation by functioning as a negative regulator of cyclin D1 expression.
Nakamura Y, Grumont RJ, Gerondakis S. Nakamura Y, et al. Mol Cell Biol. 2002 Aug;22(15):5563-74. doi: 10.1128/MCB.22.15.5563-5574.2002. Mol Cell Biol. 2002. PMID: 12101248 Free PMC article. - Temperature-sensitive transformation by an Abelson virus mutant encoding an altered SH2 domain.
Mainville CA, Parmar K, Unnikrishnan I, Gong L, Raffel GD, Rosenberg N. Mainville CA, et al. J Virol. 2001 Feb;75(4):1816-23. doi: 10.1128/JVI.75.4.1816-1823.2001. J Virol. 2001. PMID: 11160680 Free PMC article. - Activation of V(D)J recombination induces the formation of interlocus joints and hybrid joints in scid pre-B-cell lines.
Lew S, Franco D, Chang Y. Lew S, et al. Mol Cell Biol. 2000 Oct;20(19):7170-7. doi: 10.1128/MCB.20.19.7170-7177.2000. Mol Cell Biol. 2000. PMID: 10982833 Free PMC article. - Temporal analyses reveal a pivotal role for sense and antisense enhancer RNAs in coordinate immunoglobulin lambda locus activation.
Gao Z, Smith AL, Scott JNF, Bevington SL, Boyes J. Gao Z, et al. Nucleic Acids Res. 2023 Oct 27;51(19):10344-10363. doi: 10.1093/nar/gkad741. Nucleic Acids Res. 2023. PMID: 37702072 Free PMC article.
References
- Cell. 1978 Jun;14(2):203-10 - PubMed
- Cell. 1991 Jun 28;65(7):1107-15 - PubMed
- Nature. 1990 Jan 25;343(6256):377-81 - PubMed
- Cell. 1991 May 17;65(4):701-13 - PubMed
- Cell. 1991 Sep 20;66(6):1081-94 - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous